首页> 美国卫生研究院文献>BMC Cancer >Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

【2h】

Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

机译：基于伊立替康或其他药物治疗一线非小细胞肺癌IIIB / IV期一线化疗的比较：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo compare the efficacy and toxicity of irinotecan-based chemotherapy (IBC) and non-irinotecan-based chemotherapy (NIBC) as first-line treatment for stage IIIB/IV non-small cell lung cancer (NSCLC).

机译：背景为了比较基于伊立替康的化学疗法（IBC）和基于非伊立替康的化学疗法（NIBC）作为IIIB / IV期非小细胞肺癌（NSCLC）一线治疗的疗效和毒性。

著录项

期刊名称 BMC Cancer
作者
Xue-Qin Yang; Chong-Yi Li; Ming-Fang Xu; Hong Zhao; Dong Wang;
展开▼
作者单位

展开▼
年(卷),期 2015(15),-1
年度 2015
页码 949
总页数 14
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Irinotecan Chemotherapy Non-small cell lung cancer Meta-analysis;

机译：伊立替康;化学疗法;非小细胞肺癌;Meta分析;

相似文献

外文文献
中文文献
专利

1. Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis [J] . Xue-Qin Yang, Chong-Yi Li, Ming-Fang Xu, BMC Cancer . 2015,第1期

机译：基于伊立替康或其他药物的一线化疗治疗IIIB / IV期非小细胞肺癌的比较：系统评价和荟萃分析
2. Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? [J] . Karen M.Clements, GersonPeltz, Douglas E.Faries, Chemotherapy Research and Practice . 2010,第1期

机译：一线双线化疗治疗IIIB / IV期非小细胞肺癌患者的肿瘤组织学类型是否影响生存？
3. Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines [J] . Chen Hongwei, Yao Xiaojun, Li Ting, Medicine. . 2019,第52期

机译：复方禁毒注射加上铂类化学疗法IIIB / IV非小细胞肺癌：普遍指南后随机临床试验的荟萃分析的方案
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? [O] . Karen M. Clements, Gerson Peltz, Douglas E. Faries, 2010

机译：一线双线化学疗法治疗的IIIB / IV期非小细胞肺癌患者的肿瘤组织学类型是否影响生存？
7. Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis [O] . Xue-Qin Yang, Chong-Yi Li, Ming-Fang Xu, 2015

机译：基于伊立替康或其他药物治疗一线非小细胞肺癌IIIB / IV期一线化疗的比较：系统评价和荟萃分析

Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅